Literature DB >> 19557705

Methodological considerations for observational studies of acute kidney injury using existing data sources.

Matthew James1, Neesh Pannu.   

Abstract

Acute kidney injury (AKI), as defined by small, often reversible changes in kidney function, has recently been recognized as an important complication in hospitalized patients, and has been consistently associated with prolonged hospital length of stay, increased associated costs and short-term mortality. Research studies on the epidemiology of AKI must address a number of unique methodological challenges, which have the potential to impact study results and validity. This review explores several methodological issues relevant to the design and conduct of observational studies that employ preexisting laboratory, administrative or research databases and that examine AKI as an outcome or an exposure. We discuss how methodological decisions may affect study results, particularly as they relate to selection bias, misclassification and confounding. Highlighting these areas may facilitate the design of studies of high methodological rigor that advance our understanding of AKI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19557705

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  11 in total

1.  Alternative outcome definitions and their effect on the performance of methods for observational outcome studies.

Authors:  Christian G Reich; Patrick B Ryan; Martijn J Schuemie
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

2.  Reduced Mortality Associated with Acute Kidney Injury Requiring Dialysis in the United States.

Authors:  Jeremiah R Brown; Michael E Rezaee; William M Hisey; Kevin C Cox; Michael E Matheny; Mark J Sarnak
Journal:  Am J Nephrol       Date:  2016-04-29       Impact factor: 3.754

3.  Investigation of the role of nitric oxide/soluble guanylyl cyclase pathway in ascorbic acid-mediated protection against acute kidney injury in rats.

Authors:  Vaishali Koul; Anudeep Kaur; Amrit Pal Singh
Journal:  Mol Cell Biochem       Date:  2015-07-05       Impact factor: 3.396

4.  AKI in hospitalized children: epidemiology and clinical associations in a national cohort.

Authors:  Scott M Sutherland; Jun Ji; Farnoosh H Sheikhi; Eric Widen; Lu Tian; Steven R Alexander; Xuefeng B Ling
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 8.237

5.  Acute reversible kidney injury secondary to bilateral ureteric obstruction.

Authors:  Michael Organ; Richard W Norman
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

Review 6.  Chronic kidney disease following acute kidney injury-risk and outcomes.

Authors:  Kelvin C W Leung; Marcello Tonelli; Matthew T James
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314

Review 7.  eResearch in acute kidney injury: a primer for electronic health record research.

Authors:  Emily L Joyce; Dilhari R DeAlmeida; Dana Y Fuhrman; Priyanka Priyanka; John A Kellum
Journal:  Nephrol Dial Transplant       Date:  2019-03-01       Impact factor: 5.992

8.  Impact of acute kidney injury and nephrotoxic exposure on hospital length of stay.

Authors:  Justin B Searns; Katja M Gist; John T Brinton; Kaci Pickett; James Todd; Meghan Birkholz; Danielle E Soranno
Journal:  Pediatr Nephrol       Date:  2020-01-15       Impact factor: 3.714

9.  The accuracy of diagnostic coding for acute kidney injury in England - a single centre study.

Authors:  Laurie A Tomlinson; Alex M Riding; Rupert A Payne; Gary A Abel; Charles R Tomson; Ian B Wilkinson; Martin O Roland; Afzal N Chaudhry
Journal:  BMC Nephrol       Date:  2013-03-13       Impact factor: 2.388

10.  Incidence and In-Hospital Mortality of Acute Kidney Injury (AKI) and Dialysis-Requiring AKI (AKI-D) After Cardiac Catheterization in the National Inpatient Sample.

Authors:  Jeremiah R Brown; Michael E Rezaee; Elizabeth L Nichols; Emily J Marshall; Edward D Siew; Michael E Matheny
Journal:  J Am Heart Assoc       Date:  2016-03-15       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.